Continuing Education (CE)
Continuing Education (CE)
Bayer has sponsored a variety of continuing education (CE) programs, which were developed to improve awareness and understanding of hemophilia A.
All accredited CE/CME programs listed below were created independently by third-party providers and follow the standards set forth in the ACCME Standards for Commercial Support/Integrity and Independence in Accredited Continuing Education, or other similar accrediting organizations. Responsibility and control over selection, content, faculty, educational materials, and venue for the educational programs belong solely to the providers and/or accreditors. Bayer does not provide any guidance regarding the content or faculty for any programs receiving funding.
The list below is limited to CE programs supported by Bayer.
Last updated "November 2025".
Updates in Hemophilia: Approaches to the Comprehensive
Care of Women with Hemophilia A using rFVIII
Steven Pipe, MD; Maria Elisa Mancuso, MD, PhD; Leonard Valentino, MD and Angela Weyand, MD
Learning Objectives:
Describe the epidemiology, characteristics and clinical presentation of hemophilia A carriers and recognize the significance of timely and accurate diagnosis
Summarize the recent guidelines and nomenclature for managing hemophilia carriers
Recognize the importance of registering hemophilia carriers at Hemophilia Treatment Centers (HTC) to facilitate comprehensive monitoring of patients
Identify challenges faced by multidisciplinary teams in delivering comprehensive care to hemophilia carriers
1.25 CME Credit
Intended Audience: Physicians (hematologists/hemophilia specialists), nurses, other Hemophilia Treatment Center (HTC) team members, patients/caregivers, and managed care personnel
Expert perspective
Follow Us
